A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : HIV-1

Search Conditions:
Search Keyword : HIV-1
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: HIV-1
Appearance Frequency: 17452 time(s)
Long forms: 47

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
human immunodeficiency virus type 1
(16695 times)
Virology
(5353 times)
RT (881 times)
AIDS (631 times)
LTR (470 times)
1987 Relation of HTLV-4 to simian and human immunodeficiency-associated viruses.
HIV type 1
(679 times)
Virology
(250 times)
HIV (343 times)
RT (32 times)
ART (30 times)
1988 Influence of human immunodeficiency virus antibody testing on sexual behaviour in a "high-risk" population from a "low-risk" city.
HTLV-IIIB
(18 times)
Virology
(4 times)
HIV (3 times)
PBMCs (2 times)
PP (2 times)
1988 Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection.
HIV-1mt
(10 times)
Microbiology
(3 times)
CA (3 times)
CTL (1 time)
HIV-1I135L (1 time)
1999 Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assay.
HTLV-IIIB strain
(4 times)
Nursing
(2 times)
HIV (1 time)
1990 In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis.
anti-HIV type 1
(3 times)
Drug Therapy
(1 time)
BLT (1 time)
HBV (1 time)
HSPC (1 time)
2009 Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy.
HIV-1JR-CSF and HIV-1NL4-3
(2 times)
Virology
(2 times)
--- 1994 Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.
human-pathogenic immunodeficiency virus type 1
(2 times)
Microbiology
(1 time)
AID (1 time)
mA3 (1 time)
MMTV (1 time)
2019 A Protein Antagonist of Activation-Induced Cytidine Deaminase Encoded by a Complex Mouse Retrovirus.
herpes simplex virus-1
(1 time)
Virology
(1 time)
p.i (1 time)
1990 Induction of interleukin-1 alpha and beta gene transcription in mouse peritoneal exudate cells after intraperitoneal infection with herpes simplex virus-1.
10  high selectivity indices with SI=1753
(1 time)
Biochemistry
(1 time)
AIDS (1 time)
HIV (1 time)
2019 Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
11  highly virulent D-subtype HIV type-1
(1 time)
Biochemistry
(1 time)
HIV (1 time)
LTR (1 time)
Tat (1 time)
2002 Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
12  HIV envelope transmembrane glycoproteins gp41
(1 time)
Microbiological Phenomena
(1 time)
aa (1 time)
bNAbs (1 time)
LANL (1 time)
2022 HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants.
13  HIV group
(1 time)
Nutritional Sciences
(1 time)
AIDS (1 time)
1998 Urinary excretion and plasma vitamin E levels in patients with AIDS.
14  HIV RNase H
(1 time)
Biochemistry
(1 time)
--- 1998 Characterization of a folding intermediate from HIV-1 ribonuclease H.
15  HIV, HIV-C
(1 time)
Biochemical Phenomena
(1 time)
DCs (1 time)
TNTs (1 time)
2022 HIV-1 Trans Infection via TNTs Is Impeded by Targeting C5aR.
16  HIV-1 antiserum
(1 time)
Virology
(1 time)
ELISA (1 time)
2001 Comparison of the biological activities of human immunodeficiency virus 1 P24 and GP41 expressed in Spodoptera frugiperda cells by use of bac-to-bac system.
17  HIV-1 Bal
(1 time)
Allergy and Immunology
(1 time)
DCs (1 time)
2001 Activation of HIV-1-specific immune responses to an HIV-1 vaccine constructed from a replication-defective adenovirus vector using various combinations of immunization protocols.
18  HIV-1 CRF01_AE
(1 time)
Virology
(1 time)
NIH ARRRP (1 time)
RT (1 time)
2013 Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.
19  HIV-1 envelop protein MLV
(1 time)
Biotechnology
(1 time)
--- 2005 Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
20  HIV-1 replication and virus
(1 time)
Allergy and Immunology
(1 time)
--- 2003 HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.
21  HIV-1 seropositive
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
M-MDSCs (1 time)
2016 Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals.
22  HIV-1 TaqMan test v1.0
(1 time)
Virology
(1 time)
--- 2010 Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach.
23  HIV-1-antigens, we generated a MLV
(1 time)
Biotechnology
(1 time)
rhPBMCs (1 time)
2006 Retroviral vectors for vaccine development: induction of HIV-1-specific humoral and cellular immune responses in rhesus macaques using a novel MLV(HIV-1) pseudotype vector.
24  HIV-1-LTR
(1 time)
Cell Biology
(1 time)
PBLs (1 time)
1996 Activation of the transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat by autologous and heterologous cell-to-cell contact.
25  HIV-1-WI3
(1 time)
Science
(1 time)
--- 1989 Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.
26  HIV-1DeltaVif
(1 time)
Virology
(1 time)
A3A (1 time)
A3G (1 time)
CDA (1 time)
2008 Functional domain organization of human APOBEC3G.
27  HIV-1HTLV-IIIB
(1 time)
Virology
(1 time)
Env (1 time)
HIV-2 (1 time)
RIPA (1 time)
1990 Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
28  HIV-1IIIB and HIV-1RF
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
ADCC (1 time)
ELISA (1 time)
MACS (1 time)
1990 Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
29  HIV-1LAI
(1 time)
Anti-Bacterial Agents
(1 time)
F-ddA (1 time)
P119S (1 time)
RT (1 time)
1997 In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosine.
30  HIV-1RF
(1 time)
Virology
(1 time)
--- 1992 A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.
31  HIV-1SF2, HIV-1Mck and HIV-1LAI
(1 time)
Allergy and Immunology
(1 time)
HUVEC (1 time)
1995 Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1.
32  HIV-1Tg
(1 time)
Cells
(1 time)
CNS (1 time)
cSTR (1 time)
FCTX (1 time)
2022 Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.
33  HIV-GFP
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
APOBEC3G (1 time)
FACS (1 time)
MDMs (1 time)
2013 M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication.
34  HIV-positive patients, intense immunoexpression of S-100 and p24
(1 time)
Cell Biology
(1 time)
CBLL (1 time)
FNA (1 time)
HIV (1 time)
1999 HIV-1 (p24)-positive multinucleated giant cells in HIV-associated lymphoepithelial lesion of the parotid gland. A report of two cases.
35  HIV1-BaL, HIV1-JRFL and HIV1-631
(1 time)
Biochemistry
(1 time)
ADC (1 time)
IDO (1 time)
LA (1 time)
2000 Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1.
36  HIVmPIr
(1 time)
Anti-Bacterial Agents
(1 time)
PIs (1 time)
2010 Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.
37  HLA-B*3501-predicted epitopes covered 0.9
(1 time)
Allergy and Immunology
(1 time)
ANN (1 time)
BIMAS (1 time)
2002 Large-scale computational identification of HIV T-cell epitopes.
38  HTLV-III B LAI
(1 time)
Biochemistry
(1 time)
--- 2003 Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones.
39  HTLV-IIIB and HTLV-IIIRF
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
--- 1989 Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135).
40  human immuno-virus-1
(1 time)
Chemistry
(1 time)
Gly-Val-SQV (1 time)
P-gp (1 time)
SQV (1 time)
2007 Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
41  HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1
(1 time)
Virology
(1 time)
ART (1 time)
2016 [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
42  human immunodeficiency virus type 1 long terminal repeat LTR
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
CAT (1 time)
LTR (1 time)
1992 Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation.
43  Human immunodeficiency virus-1 and -2
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
AIDS (1 time)
EBV (1 time)
HBV (1 time)
2005 AIDS related viruses, their association with leukemia, and Raf signaling.
44  human immunodeficiency virus-1, LAV-1 strain
(1 time)
Cell Biology
(1 time)
--- 1990 Fluoroquinolones protect the human lymphocyte CEM cell line from HIV-1-mediated cytotoxicity.
45  Human monoclonal antibodies to type 1 immunodeficiency virus
(1 time)
Virology
(1 time)
--- 2003 [Construction and screening of type 1 human immunodeficiency virus specific phage antibodies combinatorial library].
46  Human rhinovirus type 14:human immunodeficiency virus type 1
(1 time)
Virology
(1 time)
HRV14 (1 time)
1998 Human rhinovirus type 14:human immunodeficiency virus type 1 (HIV-1) V3 loop chimeras from a combinatorial library induce potent neutralizing antibody responses against HIV-1.
47  human virus type 1
(1 time)
Rheumatology
(1 time)
PCR (1 time)
RA (1 time)
SLE (1 time)
1995 Antibodies to human immunodeficiency virus (HIV-1) in autoimmune diseases: primary Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases.